Legal Representation
Attorney
Tracy-Gene G. Durkin
USPTO Deadlines
Next Deadline
114 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
November 26, 2025
Extension Available
Until November 26, 2025
Application History
12 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 21, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 21, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 21, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 21, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 26, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 15, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 15, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 25, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 11, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 11, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 30, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 21, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, biological preparations, and cell- and gene-based therapy products to prevent and treat age-related cardiovascular disease, neurodegenerative disease, musculoskeletal disease, pulmonary disease, metabolic disease, diseases of the liver, macular degeneration and other ocular diseases, kidney disease, and cancer; pharmaceutical preparations, biological preparations, and cell- and gene-based therapy products to prevent and treat cardiovascular disease, neurodegenerative disease, musculoskeletal disease, pulmonary disease, metabolic disease, diseases of the liver, macular degeneration and other ocular diseases, kidney disease, and cancer
Class 042
Pharmaceutical and biological drug research and development services; research and development of pharmaceutical and biotechnology fields, namely, cell- and gene-based therapy research and development services; providing information about medical and scientific research on aging and complex multigenic diseases; providing information about medical and scientific research, namely, providing information on pharmaceutical drug, biological drug, and cell- and gene-based therapy research and development; providing scientific information on computational biology, machine learning, and bioinformatics
Class 044
Providing medical information on aging and complex multigenic diseases
Additional Information
Design Mark
The mark consists of the wording "Gordian" with a partial "a" and a diagonal edge extending from the top of the letter "d" to the bottom of the letter "a".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
042
044